Nexus Children’s Hospital – Dallas Partners with Pediatric Acute Care Associates to Improve Continuity of Care

Nexus Health Systems is pleased to announce a partnership between Nexus Children’s Hospital – Dallas and Pediatric Acute Care Associates of North Texas which will give pediatric patients at Medical City Hospital Dallas access to coordinated step-down care. Led by Dr. Michele Papo, this partnership creates a more continuous experience for those moving from a pediatric intensive care unit (PICU) to Nexus’ transitional care unit.

“We are thrilled to partner with Dr. Papo and Pediatric Acute Care Associates of North Texas to provide a more seamless transition from intensive to transitional care,” said Nexus Children’s Hospital – Dallas CEO Roger Caron. “Dr. Papo and her team have a proven track record of providing exceptional care for medically complex patients. Together, we can ensure they experience a smooth transition from critical care to lower acuity levels of treatment and rehabilitation.”

Located 15 minutes east of the Dallas Medical Center, Nexus Children’s Hospital provides complex post-acute care for infants, children, adolescents and young adults in a state-of-the-art facility. The hospital’s interdisciplinary team creates specialized treatment plans to address debilitating conditions such as brain and spinal cord injuries, neurodevelopmental delays and co-occurring medical, behavioral and mental health needs.

Nexus specializes in providing transitional care for young patients who have stabilized in the PICU but are not yet ready to return home. The partnership with Pediatric Acute Care Associates of North Texas makes it easier for caregivers to identify Nexus as an option, while minimizing disruptions that can occur when patients transfer between health care facilities.

“Continuous care has been shown to improve outcomes, increase patient satisfaction, lower the risk of hospital readmission and decrease overall health care costs,” Caron said. “We are dedicated to meeting the Dallas area’s need for high-quality, coordinated care that extends beyond the acute phase of recovery.”

Since 1999, Nexus has developed programs to meet the most pressing needs of pediatric patients across the country. Current transitional care programs at Nexus Children’s Hospital – Dallas include Harbor, which provides rehabilitation and ongoing medical care after complex injuries and illnesses, and Rise, which offers rehabilitation and ongoing medical care after brain and spinal cord injury, stroke, and other neurological illnesses and injuries.

“Nexus’ mission has always been to help individuals return to lives of productivity and meaning, wherever they are in their post-acute journey,” Caron said. “Our Dallas campus continues to provide the nationally recognized care Nexus Health Systems is known for, with a special emphasis on pediatric post-acute care.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”